These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

182 related articles for article (PubMed ID: 10698508)

  • 1. Dissociation of p53-mediated suppression of homologous recombination from G1/S cell cycle checkpoint control.
    Willers H; McCarthy EE; Wu B; Wunsch H; Tang W; Taghian DG; Xia F; Powell SN
    Oncogene; 2000 Feb; 19(5):632-9. PubMed ID: 10698508
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The interaction of p53 with replication protein A mediates suppression of homologous recombination.
    Romanova LY; Willers H; Blagosklonny MV; Powell SN
    Oncogene; 2004 Dec; 23(56):9025-33. PubMed ID: 15489903
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Suppression of the p53- or pRB-mediated G1 checkpoint is required for E2F-induced S-phase entry.
    Lomazzi M; Moroni MC; Jensen MR; Frittoli E; Helin K
    Nat Genet; 2002 Jun; 31(2):190-4. PubMed ID: 11992123
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Cell cycle control by p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. I. Regulation of p53 expression.
    Steinmeyer K; Maacke H; Deppert W
    Oncogene; 1990 Nov; 5(11):1691-9. PubMed ID: 2267135
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Increase of spontaneous intrachromosomal homologous recombination in mammalian cells expressing a mutant p53 protein.
    Bertrand P; Rouillard D; Boulet A; Levalois C; Soussi T; Lopez BS
    Oncogene; 1997 Mar; 14(9):1117-22. PubMed ID: 9070661
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Homologous recombination induced by replication inhibition, is stimulated by expression of mutant p53.
    Saintigny Y; Lopez BS
    Oncogene; 2002 Jan; 21(3):488-92. PubMed ID: 11821962
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Maintenance of genomic integrity by p53: complementary roles for activated and non-activated p53.
    Albrechtsen N; Dornreiter I; Grosse F; Kim E; Wiesmüller L; Deppert W
    Oncogene; 1999 Dec; 18(53):7706-17. PubMed ID: 10618711
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Prevention of mammalian DNA reduplication, following the release from the mitotic spindle checkpoint, requires p53 protein, but not p53-mediated transcriptional activity.
    Notterman D; Young S; Wainger B; Levine AJ
    Oncogene; 1998 Nov; 17(21):2743-51. PubMed ID: 9840938
    [TBL] [Abstract][Full Text] [Related]  

  • 9. XRCC4 in G1 suppresses homologous recombination in S/G2, in G1 checkpoint-defective cells.
    Saintigny Y; Delacôte F; Boucher D; Averbeck D; Lopez BS
    Oncogene; 2007 Apr; 26(19):2769-80. PubMed ID: 17057732
    [TBL] [Abstract][Full Text] [Related]  

  • 10. p53 modulates base excision repair activity in a cell cycle-specific manner after genotoxic stress.
    Offer H; Zurer I; Banfalvi G; Reha'k M; Falcovitz A; Milyavsky M; Goldfinger N; Rotter V
    Cancer Res; 2001 Jan; 61(1):88-96. PubMed ID: 11196204
    [TBL] [Abstract][Full Text] [Related]  

  • 11. p53/p21(CIP1) cooperate in enforcing rapamycin-induced G(1) arrest and determine the cellular response to rapamycin.
    Huang S; Liu LN; Hosoi H; Dilling MB; Shikata T; Houghton PJ
    Cancer Res; 2001 Apr; 61(8):3373-81. PubMed ID: 11309295
    [TBL] [Abstract][Full Text] [Related]  

  • 12. A transcriptional activation function of p53 is dispensable for and inhibitory of its apoptotic function.
    Kokontis JM; Wagner AJ; O'Leary M; Liao S; Hay N
    Oncogene; 2001 Feb; 20(6):659-68. PubMed ID: 11313999
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A novel human p53 isoform is an essential element of the ATR-intra-S phase checkpoint.
    Rohaly G; Chemnitz J; Dehde S; Nunez AM; Heukeshoven J; Deppert W; Dornreiter I
    Cell; 2005 Jul; 122(1):21-32. PubMed ID: 16009130
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Cell cycle control of p53 in normal (3T3) and chemically transformed (Meth A) mouse cells. II. Requirement for cell cycle progression.
    Deppert W; Buschhausen-Denker G; Patschinsky T; Steinmeyer K
    Oncogene; 1990 Nov; 5(11):1701-6. PubMed ID: 2267136
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Suppression of replication fork progression in low-dose-specific p53-dependent S-phase DNA damage checkpoint.
    Shimura T; Toyoshima M; Adiga SK; Kunoh T; Nagai H; Shimizu N; Inoue M; Niwa O
    Oncogene; 2006 Sep; 25(44):5921-32. PubMed ID: 16682953
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Inactivation of p53 results in high rates of homologous recombination.
    Mekeel KL; Tang W; Kachnic LA; Luo CM; DeFrank JS; Powell SN
    Oncogene; 1997 Apr; 14(15):1847-57. PubMed ID: 9150391
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Loss of normal G1 checkpoint control is an early step in carcinogenesis, independent of p53 status.
    Syljuåsen RG; Krolewski B; Little JB
    Cancer Res; 1999 Mar; 59(5):1008-14. PubMed ID: 10070956
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Association of p53 and MSH2 with recombinative repair complexes during S phase.
    Zink D; Mayr C; Janz C; Wiesmüller L
    Oncogene; 2002 Jul; 21(31):4788-800. PubMed ID: 12101417
    [TBL] [Abstract][Full Text] [Related]  

  • 19. p53 modulates homologous recombination at I-SceI-induced double-strand breaks through cell-cycle regulation.
    Rieckmann T; Kriegs M; Nitsch L; Hoffer K; Rohaly G; Kocher S; Petersen C; Dikomey E; Dornreiter I; Dahm-Daphi J
    Oncogene; 2013 Feb; 32(8):968-75. PubMed ID: 22484423
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Activation of the p53-dependent G1 checkpoint response in mouse embryo fibroblasts depends on the specific DNA damage inducer.
    Attardi LD; de Vries A; Jacks T
    Oncogene; 2004 Jan; 23(4):973-80. PubMed ID: 14749764
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.